290 related articles for article (PubMed ID: 11120946)
1. Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents.
Credito KL; Lin G; Pankuch GA; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2001 Jan; 45(1):67-72. PubMed ID: 11120946
[TBL] [Abstract][Full Text] [Related]
2. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
[TBL] [Abstract][Full Text] [Related]
3. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
Peric M; Browne FA; Jacobs MR; Appelbaum PC
Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
[TBL] [Abstract][Full Text] [Related]
4. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
Pottumarthy S; Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.
Zhanel GG; Palatnick L; Nichol KA; Low DE; Hoban DJ;
Antimicrob Agents Chemother; 2003 Jun; 47(6):1875-81. PubMed ID: 12760861
[TBL] [Abstract][Full Text] [Related]
7. Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis.
Davies TA; Kelly LM; Hoellman DB; Ednie LM; Clark CL; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Mar; 44(3):633-9. PubMed ID: 10681330
[TBL] [Abstract][Full Text] [Related]
8. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
[TBL] [Abstract][Full Text] [Related]
9. Comparative antimicrobial activity and kill-curve investigations of novel ketolide antimicrobial agents (HMR 3004 and HMR 3647) tested against Haemophilus influenzae and Moraxella catarrhalis strains.
Biedenbach DJ; Barrett MS; Jones RN
Diagn Microbiol Infect Dis; 1998 Jun; 31(2):349-53. PubMed ID: 9635909
[TBL] [Abstract][Full Text] [Related]
10. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
Pfaller MA; Farrell DJ; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
[TBL] [Abstract][Full Text] [Related]
11. Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
Credito KL; Ednie LM; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1999 Aug; 43(8):2027-31. PubMed ID: 10428930
[TBL] [Abstract][Full Text] [Related]
12. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group.
Blondeau JM; Suter M; Borsos S
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():25-30. PubMed ID: 10225568
[TBL] [Abstract][Full Text] [Related]
13. Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides.
Drago L; De Vecchi E; Nicola L; Colombo A; Gismondo MR
J Antimicrob Chemother; 2004 Aug; 54(2):542-5. PubMed ID: 15215227
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of ABT-773 versus macrolides and quinolones against resistant respiratory tract pathogens.
Dubois J; St -Pierre C
Diagn Microbiol Infect Dis; 2001; 40(1-2):35-40. PubMed ID: 11448561
[TBL] [Abstract][Full Text] [Related]
16. Antipneumococcal activity of ABT-773 compared to those of 10 other agents.
Davies TA; Ednie LM; Hoellman DM; Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Jul; 44(7):1894-9. PubMed ID: 10858350
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of the ketolide ABT-773.
Barry AL; Fuchs PC; Brown SD
Antimicrob Agents Chemother; 2001 Oct; 45(10):2922-4. PubMed ID: 11557491
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
Brueggemann AB; Doern GV; Huynh HK; Wingert EM; Rhomberg PR
Antimicrob Agents Chemother; 2000 Feb; 44(2):447-9. PubMed ID: 10639382
[TBL] [Abstract][Full Text] [Related]
19. Kinetic bactericidal activity of telithromycin, azithromycin and clarithromycin against respiratory pathogens.
Drago L; De Vecchi E; Nicola L; Legnani D; Gismondo MR
APMIS; 2005 Oct; 113(10):655-63. PubMed ID: 16309423
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of telithromycin compared with macrolides and fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
Küçükbasmaci O; Gönüllü N; Aktaş Z; Gürol D; Berkiten R
Int J Antimicrob Agents; 2003 Nov; 22(5):497-501. PubMed ID: 14602368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]